BIO.B Stock Summary and Trading Ideas (Bio-Rad Laboratories Class B | NYSE:BIO.B)

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories Class B trades on the NYSE stock market under the symbol BIO.B.

As of May 13, 2024, BIO.B stock price was flat at $279.91 with 2 million shares trading.

BIO.B has a market cap of $8.13 billion. This is considered a Mid Cap stock.

In the last 3 years, BIO.B stock traded as high as $829.01 and as low as $271.00.

BIO.B has underperformed the market in the last year with a price return of -25.1% while the SPY ETF gained +27.8%. BIO.B has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.8% and 0.0%, respectively, while the SPY returned +4.3% and +2.5%, respectively.

BIO.B support price is $263.37 and resistance is $296.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIO.B stock will trade within this expected range on the day.